Becker's Healthcare January 27, 2025
Andrew Cass

Sources told CNBC’s David Faber that a private equity firm’s prospective deal to acquire Walgreens Boots Alliance is “mostly dead,” The Wall Street Journal reported Jan. 27.

Five things to know:

1. The Journal reported in December that Walgreens was in talks to sell itself to Sycamore Partners and become private. The news outlet reported at the time that the deal could be wrapped as early as in 2025.

2. The Justice Department on Jan. 16 sued Walgreens and its subsidiaries alleging unlawful dispensation of millions of prescriptions in violation of the Controlled Substances Act. That lawsuit potentially complicated talks between Walgreens and the...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Pharma, Pharma / Biotech
From discovery to delivery: Finding an investment edge in biopharma services
Trump administration affirms drug price talks, but will seek input to ‘improve’ program
Healthcare’s outlook in 2025: New administration spells uncertainty, but hope remains
World's most admired healthcare companies: Fortune
Walgreen's private equity sale likely abandoned: 5 things ASCs need to know

Share This Article